Extra (non-contingent) food does not affect behavioral tolerance to d-amphetamine's rate-decreasing effects

Pharmacology, Biochemistry, and Behavior
Christopher A Krebs, K.G. Anderson

Abstract

Tolerance refers to the diminished effect of a drug following its repeated administration such that a larger dose is needed to obtain the initial effect. Tolerance to a drug's effects on operant behavior is more likely to develop when initial drug administration results in a loss of reinforcement. It remains unknown how offsetting loss of reinforcement influences the development of tolerance. Providing extra (non-contingent) food pellets was hypothesized to impede the development of tolerance to effects of a repeatedly administered dose of d-amphetamine that reduced the number of food pellets earned by rats. A multiple schedule with two variable-interval (VI) 60-s components resulting in food delivery was used to maintain lever pressing. Extra food pellets were provided in one of those components according to a variable-time (VT) 120-s or a VT 30-s schedule for separate groups of rats (n=6 for each group). Effects of d-amphetamine (0.1-3.0mg/kg) were tested before (acute) and during (chronic) injections (45days) of an individually selected, repeatedly administered dose that reduced the number of food pellets earned by at least 50% compared to when saline was tested acutely. There was a dose-dependent decrease in lever-press rat...Continue Reading

References

Aug 1, 1990·Pharmacology, Biochemistry, and Behavior·J B Smith
May 1, 1990·Journal of the Experimental Analysis of Behavior·J A NevinR L Shull
Jan 1, 1989·Pharmacology, Biochemistry, and Behavior·K F Schama, M N Branch
May 1, 1987·Journal of the Experimental Analysis of Behavior·S H HoffmanG M Sizemore
Jan 1, 1966·Psychopharmacologia·C R SchusterJ H Woods
Jan 1, 1996·Journal of the Experimental Analysis of Behavior·C E HughesM N Branch
Jan 1, 1993·Behavioural Pharmacology·J. Stewart, A. Badiani
Aug 7, 2003·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Joshua M GulleyNancy R Zahniser
Oct 1, 1962·Journal of the Experimental Analysis of Behavior·M FLESHLER, H S HOFFMAN
Jul 30, 2005·Journal of the Experimental Analysis of Behavior·Christine E HughesLinda A Dykstra
Jun 17, 2006·Journal of the Experimental Analysis of Behavior·Marc N Branch
Mar 1, 1970·Journal of the Experimental Analysis of Behavior·R J Herrnstein
Sep 1, 1972·Journal of the Experimental Analysis of Behavior·H Rachlin, W M Baum
May 1, 1979·Journal of the Experimental Analysis of Behavior·M D Zeiler
Jan 1, 1986·Journal of the Experimental Analysis of Behavior·I S Burgess, J H Wearden
Jan 13, 2009·Drug and Alcohol Dependence·Marilyn E CarrollJennifer L Perry
May 26, 2009·Pharmacology, Biochemistry, and Behavior·Dustin J Stairs, Michael T Bardo
Nov 9, 2010·Psychopharmacology·Cassandra D GipsonMichael T Bardo
Feb 1, 2011·Journal of the Experimental Analysis of Behavior·Jonathan W Pinkston, Marc N Branch
Apr 15, 2011·Pharmacological Reviews·Jeffery D Steketee, Peter W Kalivas
Nov 15, 2011·Pharmacology, Biochemistry, and Behavior·Anne C Macaskill, Marc N Branch
Oct 1, 1988·The Behavior Analyst·J J McDowell
Jun 1, 2012·Behavior Analysis in Practice·Derek D Reed, Brent A Kaplan
Sep 11, 2013·Journal of the Experimental Analysis of Behavior·Vanessa Minervini, Marc N Branch

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anti-Arrhythmic Drug Therapies

Anti-arrhythmic drugs are used to prevent abnormal heart rhythms. These medications are used in conditions including, ventricular tachycardia, ventricular fibrillation and atrial fibrillation. Discover the latest research on anti-arrhythmic drug therapies here.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.